Skip to main content

Advertisement

Log in

Nonoperative management of spasticity in children

  • Special Annual Issue
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Central to the longitudinal management of childhood hypertonia are nonsurgical treatments. These include physical and occupational therapy, electrical stimulation, orthotics, botulium toxin, and drugs. This manuscripts reviews these treatment modalities as well as evaluation tools available to assess their impact on a child’s hypertonia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Abel MF, Juhl GA, Vaughn CL, Damiano DL (1998) Gait assessment of fixed ankle-foot orthoses in children with spastic diplegia. Arch Phys Med Rehabil 79:126–133

    PubMed  CAS  Google Scholar 

  2. Albright AL, Awaad Y, Muhonan M, Boydston WK, Gilmartin R, Krach LE, Turner M, Zidek KA, Wright E, Swift D, Bloom K (2004) Performance and complications associatied with the Synchromed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 101(1 Suppl):64–68

    PubMed  Google Scholar 

  3. Allison SC, Abraham LD (2001) Sensitivity of qualitative and quantitative measures to clinical treatment with cryotherapy. Int J Rehabil Res 24(1):15–24

    PubMed  CAS  Google Scholar 

  4. Andersson C, Grootern W, Hellsten M, Kaping K, Mattsson E (2003) Adults with cerebral palsy: walking ability after progressive strength training. Dev Med Child Neurol 45(4):220–228

    PubMed  CAS  Google Scholar 

  5. Ansari NN, Adelmanesh F, Naghdi S, Tabtabaei A (2006) The effect of physiotherapeutic ultrasound on muscle spasticity in patients with hemiplegia: a pilot study. Electromyogr Clin Neurophysiol 46(4):247–252

    PubMed  CAS  Google Scholar 

  6. Ansved T, Odergren T, Borg K (1997) Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment in cervical dystonia. Neurology 48:1440–1442

    PubMed  CAS  Google Scholar 

  7. Arens LJ, Goldschmidt RB, Leary PM (1997) Botulinum toxin A in the hemiplegic upper extremity. Dev Med Child Neurol 39:185–193

    Google Scholar 

  8. Autti-Ramo I, Suoranta J, Anttila H, Malmivaara A, Makela M (2006) Effectiveness of upper and lower limb casting and orthoses in children with cerebral palsy: an overview of review articles. Am J Phys Med Rehabil 85:89–103

    PubMed  Google Scholar 

  9. Bar-Haim S, Harries N, Belokopytov H, Frank A, Copeliovitch L, Kaplanski I, Lahat E (2006) Comparison of efficacy of Adeli suit and neurodevelopmental treatment in children with cerebral palsy. Dev Med Child Neurol 48(6):325–330

    PubMed  Google Scholar 

  10. Barry M, Albright L, Shultz B (2000) Intrathecal Baclofen therapy and the role of the physical therapist. Pediatr Phys Ther 12(2):77–86

    Google Scholar 

  11. Battin MR, Dezoete JA, Gunn TR, Gluckman PD, Gunn AJ (2001) Neurodevelopmental outcome of infants treated with head cooling and mild hypothermia after perinatal asphyxia. Pediatr 107:480–484

    CAS  Google Scholar 

  12. Bayram S, Sivriogllu K, Karli N, Ozcan O (2006) Low-dose botulinum toxin with short-term electrical stimulation in post stroke spastic drop foot: a preliminary study. Am J Phys Med Rehabil 85(1):75–81

    PubMed  Google Scholar 

  13. Bertolli DB (1986) Effect of short leg casting on ambulation in children with cerebral palsy. Phys Ther 66:1522–1529

    Google Scholar 

  14. Bleck EE (1987) Orthopedic management of cerebral palsy. Clinical developmental medicine, vol. 99/100. MacKeith, Oxford

    Google Scholar 

  15. Bobath K (1980) A neurophysiologic basis to the treatment of cerebral palsy. Spastics International, Laveham, UK

    Google Scholar 

  16. Bohannon RW, Smith MB (1987) Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67:206–207

    PubMed  CAS  Google Scholar 

  17. Booth MY, Yates CC, Edgar TS, Bandyu WD (2003) Serial casting vs. combined intervention with botulinum toxin A and serial casting in the treatment of spastic equinus in children. Pediatr Phys Ther 15(4):216–220

    PubMed  Google Scholar 

  18. Bottos M, Benedetti MG, Salucci P, Gasparroni V, Gianni S (2003) Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment. Dev Med Child Neurol 45(11):758–762

    PubMed  CAS  Google Scholar 

  19. Brouwer B, Wheeldon RK, Stradiotto-Parker N, Allum J (1998) Reflex ecitability and isometric force production in cerebral palsy: the effect of serial casting. Dev Med Child Neurol 40(3):168–175

    Article  PubMed  CAS  Google Scholar 

  20. de Bruin H, Russell DJ, Latter JE, Sadler JT (1982) Angle-angle diagrams in monitoring and quantification of gait patterns in children with cerebral palsy. Am J Phys Med 61:176–192

    PubMed  Google Scholar 

  21. Burtner PA, Woollacott MH, Qualls C (1999) Stance balance control with orthoses in a group of children with spastic cerebral palsy. Dev Med Child Neurol 41(11):748–757

    PubMed  CAS  Google Scholar 

  22. Capute AJ (1978) Primitive reflex profile. University Park Press, Baltimore

    Google Scholar 

  23. Carda S, Molteni F (2005) Taping versus electrical stimulation after botulinum type A injection for wrist and finger spasticity. A case–control study. Clin Rehabil 19(6):621–626

    PubMed  Google Scholar 

  24. Carlson WE, Vaughn CL, Damiano DL, Abel MF (1997) Orthotic management of gait in spastic diplegia. Am J Phys Med Rehabil 76(3):219–225

    PubMed  CAS  Google Scholar 

  25. Carmick C (1997) Use of neuromuscular electrical stimulation and a dorsal wriest splint to improve hand function of a child with spastic hemiparesis. Phys Ther 77(6):661–671

    PubMed  CAS  Google Scholar 

  26. Childers MK, Biswass S, Petroski G, Merveille O (1999) Inhibitory casting decreases a vibratory inhibition index of the H-reflex in the spastic upper-limb. Arch Phys Med Rehabil 84:483–491

    Google Scholar 

  27. Chin TY, Nattrass GR, Selber P, Graham HK (2005) Accuracy of intramuscular injection of Botulinum Toxin A in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 25:286–291

    PubMed  Google Scholar 

  28. Chu ML, Sala DA (2006) The use of tiagabine in pediatric spasticity management. Dev Med Child Neurol 48(6):456–459

    PubMed  Google Scholar 

  29. Clopton N, Dutton J, Featherston T, Grigsby A, Mobley J, Melvin J (2005) Interrater and intrarater reliability of the Modified Ashworth Scale in children with hypertonia. Pediatr Phys Ther 17(4):268–274

    PubMed  Google Scholar 

  30. Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK (1998) Botulinum Toxin A compared with stretching casts in the treatment of spastic equinus: a randomized prospective trial. J Pediatr Orthop 18:304–311

    PubMed  CAS  Google Scholar 

  31. Cosgrove AP, Graham HK (1991) Botulinum toxim A presents the development of contractures isn the hereditary spastic mouse. Dev Med Child Neurol 33:730–736

    Google Scholar 

  32. Costa J, Borges A, Espirito-Santo C, Ferreira J, Coelho M, Moore P, Sampaio C (2005) Botulinum toxin type A versus botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev 25(1):CD004314 (Review)

    Google Scholar 

  33. Crenshaw S, Herzog R, Castagno P, Richards J, Miller F, Michaloski GC, Moran E (2000) The efficacy of tone-reducing splints in children with spastic diplegic cerebral palsy. J Pediatr Orthop 20(2):210–216

    PubMed  CAS  Google Scholar 

  34. Damiano DL, Vaughan CL, Abel MF (1995) Muscle response to heavy resistance exercise in children with spastic cerebral palsy. Dev Med Child Neurol 37:731–739

    Article  PubMed  CAS  Google Scholar 

  35. Damiano DL, Gilgannon MD, Abel MF (2005) Responsiveness and uniqueness of the Pedaitric Outcomes Data Collection Instrument compared to the Gross Motor Function Measure for measuring orthopedic and neurosurgical outcomes in cerebral palsy. J Pediatr Orthop 25(5):641–645

    PubMed  Google Scholar 

  36. Diachman J, Johnston TE, Evans K, Tecklin JS (2003) The effects of a neuromuscular electrical stimulation home program on impairments and functional skills of a child with spastic diplegic cerebral palsy: a case report. Pediatr Phys Ther 15(3):153–158

    Google Scholar 

  37. Dimitrijevic M, Stokic D, Wun C (1996) Modification of motor control of wrist extension by mesh-glove electrical afferent stimulation in stroke patients. Arch Phys Med Rehabil 77(3):252–258

    PubMed  CAS  Google Scholar 

  38. Duncan B, Barton L, Edmonds D, Blashill BM (2004) Parental perceptions of the therapeutic efficacy of osteopathic manipulation or acupuncture in children with spastic cerebral palsy. Clin Pediatr 43(4):349–353

    CAS  Google Scholar 

  39. Duncan WR (1960) Tonic reflexes of the foot. J Bone Jt Surg 42-A(75):859–868

    CAS  Google Scholar 

  40. Dursen E, Dursen N, Alican D (2004) Effects of biofeedback treatment on gait in children with cerebral palsy. Disabil Rehabil 26(2):116–120

    Google Scholar 

  41. Eliasson AC, Krumlinde-suncholm L, Shaw K, Wang C (2005) Effects of constraint-induced movement therapy in young children with hemiplegic cerebral palsy: an adaptive model. Dev Med Child Neurol 47(4):266–275

    PubMed  Google Scholar 

  42. Engle H (1966) The effect of diazepam (Valium) in children with cerebral palsy: a double-blind study. Dev Med Child Neurol 8:661–667

    Article  PubMed  CAS  Google Scholar 

  43. Farmer SF, Harrison LM, Ingram DA, Stephens JA (1991) Plasticity of central motor pathways in children with hemiplegic cerebral palsy. Neurology 41:1505–1510

    PubMed  CAS  Google Scholar 

  44. Fatagi Y, Abe J (1985) H-reflex study in normal children and patients with cerebral palsy. Brain Develop 7(4):414–420

    Google Scholar 

  45. Feldman AB, Haley SM, Coryell J (1990) Concurrent and construct validity of the Pediatric Evaluation of Disability Inventory. Phys Ther 70:602–610

    PubMed  CAS  Google Scholar 

  46. Fetters L, Figueiredo EM, Keane-Miller D, McSwenneny DJ, Tsao C (2004) Constraint induced therapy (??). Pediatr Phys Ther 16(1):77–79

    Google Scholar 

  47. Fowler EG, Ho TW, Nwigwe AI, Dorey FJ (2001) The effect of quadriceps femoris muscle strengthening exercises on spasticity in children with cerebral palsy. Phys Ther 81(6):1215–1223

    PubMed  CAS  Google Scholar 

  48. Friden J, Lieber R (2003) Spastic muscle cells are short and stiffer than normal cells. Muscle Nerve 26:157–164

    Google Scholar 

  49. Gage JR (1993) Gait analysis: an essential tool in the treatment of cerebral palsy. Clin Orthop 288:126–134

    PubMed  Google Scholar 

  50. Galvin KA (1998) Postinjury magnesium sulfate treatment is not markedly neuroprotective for striatal medium spiny neurons after perinatal hypoxic/ischemia in the rate. Pediatr Res 44:740–745

    PubMed  CAS  Google Scholar 

  51. Glanzman AM, Kim H, Swaminathan K, Beck T (2004) Efficacy of botulinum toxin A, serial casting, and combine treatment for spastic equinus: a retrospective analysis. Dev Med Child Neurol 46(12):807–811

    PubMed  Google Scholar 

  52. Goldstein EM (2006) Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity. J Child Neurol 21(3):189–192

    PubMed  Google Scholar 

  53. Gormley ME, Gaebler-Spira D, Delgado MR (2001) Use of botulinum type A in pediatric patients with cerebral palsy. A three-center retrospective chart review. J Child Neurol 16:113–118

    PubMed  CAS  Google Scholar 

  54. Gosechel H, Wohlfarth K, Frevert J, Dengler R, Bigalke H (1997) Botulinum A toxin therapy: neutralizing and non-neutralizing antibodies—therapeutic consequences. Exp Neurol 147:96–102

    Google Scholar 

  55. Gracies J, Nance P, Elovic E, McGuire J, Simpson DM (1997) Traditional pharmacologic treatment for spasticity. Part II. General and regional treatment. Muscle Nerve Suppl 6:100

    Google Scholar 

  56. Granger CV (1987) Guide for the use of the Functional Independence Measure for Children (WeeFIM) of the uniform data set for medical rehabilitation. Research Foundation, State University of New York, Buffalo, NY

    Google Scholar 

  57. Graham HK, Harvey A, Rodda J, Nattrass GR, Pirpiris M (2004) The functional mobility scale. J Pediatr Orthop 24(5):514–520

    PubMed  Google Scholar 

  58. Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S (1986) Determining optimal therapy: randomized trials in individual patients. N Engl J Med 314:889–892

    Article  PubMed  CAS  Google Scholar 

  59. Haley SM, Ludlow LH, Coster WJ (1993) Pediatric evauation of disability inventory. Phys Med Rehabil North Am 4(3):529–540

    Google Scholar 

  60. Halpern D, Meelhuysen FE (1982) Duration of relaxation after intramuscular neurolysis with phenol. JAMA 247:1473–1476

    Google Scholar 

  61. Hansel DE, Hansel CRW, Shinale MK, Reinhardt EM, Madden L, Levey EB, Johnston MV, Hoon AH (2003) Oral baclofen in cerebral palsy: possible seizure potentiation. Pediatr Neurol 29(3):203–206

    PubMed  Google Scholar 

  62. Hazneci B, Tan AK, Guncikan MN, Dincer K, Kalyon TA (2006) Comparison of the efficacies of boutlinum toxin A and Johnstone pressure splints against hip adductor spasticity among patients with cerebral palsy: a randomized trial. Mil Med 171(7):653–656

    PubMed  Google Scholar 

  63. Harris SR (1989) Early diagnosis of spastic diplegia, spastic hemiplegia and quadriplegia. Am J Dis Child 143:1353–1360

    Google Scholar 

  64. Harrison A (1988) Spastic cerebral palsy: possible spinal interneuronal contributions. Dev Med Child Neurol 30:769–780

    Article  PubMed  CAS  Google Scholar 

  65. Haslam R, Walcher J, Lietman PS (1974) Dantrolene sodium in children with spasticity. Arch Phys Med Rehabil 55:384–387

    PubMed  CAS  Google Scholar 

  66. Hinderer KA, Harris SR, Purdy AH, Chew DE, Staheli LT, Mc Laughlin JF, Jaffe KM (1988) Effects of tone reducing versus standard palster cases of gait improvement in children with cerebral palsy. Dev Med Child Neurol 30:370–377

    Article  PubMed  CAS  Google Scholar 

  67. Hirtz DG, Nelson K (1998) Magnesium sulfate and cerebral palsy in premature infants. Curr Opin Pediatr 10:131–137

    PubMed  CAS  Google Scholar 

  68. Hoving MA, van Kranen-Mastenbroek VHJM, van Raak EPM, Spincemaille GHJJ, Hardy ELM, Vies JSH (2006) Placebo controlled utility and feasiability study of the H-reflex and flexor reflex in spastic children treated with intrathecal baclofen. Clin Neurophysiol 117(7):1508–1517

    PubMed  CAS  Google Scholar 

  69. Huang H, Merver V, Thorpe D (2003) Effects of different concurrent cognitive tasks on temporal-distance gait variables in children. Pediatr Phys Ther 15:105–113

    PubMed  Google Scholar 

  70. Hurvitz EA, Leonard C, Ayyangar R, Nelson VS (2003) Complementary and alternative medicine use in families of children with cerebral palsy. Dev Med Child Neurol 45:364–370

    PubMed  Google Scholar 

  71. Karman N, Maryles J, Baker RW, Simpser E, Berger-Gross P (2003) Constraint-induced movement therapy for hemiplegic children with acquired brain injuries. J Head Trauma Rehabil 18(3):259–267

    PubMed  CAS  Google Scholar 

  72. Kassover M, Tauber C, Au J, Pugh J (1986) Auditory biofeedback in spastic diplegia. J Orthop Res 4:246–249

    PubMed  CAS  Google Scholar 

  73. Katrak PH, Cole AM, Poulos CJ, McCauley JC (1992) Objective assessment of spasticity, strength and function with early exhibition of Dantrolene sodum after cerebrovascular accident: a randomized double blind trial. Arch Phys Med Rehabil 73:4–9

    PubMed  CAS  Google Scholar 

  74. Katz RT, Campagnolo DI (1994) Pharmacologic management of spasticity. Phys Med Rehabil 8:473–480

    Google Scholar 

  75. Kerem M, Livanelioglu A, Topcu M (2001) Effects of Johnstone pressure splints combined with neurodevelopmental therapy on spasticity and cutaneous sensory inputs in spastic cerebral palsy. Dev Med Child Neurol 43(5):307–313

    PubMed  CAS  Google Scholar 

  76. Khalili A, Betts HB (1967) Peripheral nerve block with phenol in the management of spasticity. JAMA 260(13):1155–1157

    Google Scholar 

  77. Kilgoor G, McNair P, Stott NS (2003) Intrarater reliability of lower limb saggital range-of-motion measures in children with spastic diplegia. Dev Med Child Neurol 45(6):391–399

    Google Scholar 

  78. Knutsson E, Mattsson E (1969) Effects of local cooling on monosynaptic reflexes in man. Scand J Rehabil Med 2:159–163

    Google Scholar 

  79. Korman LA, Mooney JF, Smith B, Goodman A (1993) Management of cerebral palsy with Botulinum-A toxin: preliminary investigation. J Pediatr Orthop 13:489–495

    Google Scholar 

  80. Krach LE (2001) Pharmacotherapy of spasticity: oral medications and intrathecal blacofen. J Child Neurol 16(1):31–36

    PubMed  CAS  Google Scholar 

  81. Lagalla G, Danni M, Reiter F, Ceravalo M, Provinciali L (2000) Post-stroke spasticity management with repeated botulinum toxin injection in the upper limb. Am J Phys Med Rehabil 79(4):377–384

    PubMed  CAS  Google Scholar 

  82. Lance JW (1980) Symposium synopsis. In: Fledman RG, Young RR, Koella WP (eds) Spasticity: disordered motor control. Yearbook, Chicago, pp 485–494

    Google Scholar 

  83. Law M, Cadman D, Rosenbaum P, Walter S, Russell D, DeMatteo C (1991) Neurodevelopmental therapy and upper-extremity inhibitive casting for children with cerebral palsy. Dev Med Child Neurol 33:379–387

    Article  PubMed  CAS  Google Scholar 

  84. Lee JM, Warren MP, Mason SM (1978) Effects of ice on nerve conduction celocity. Physiotherapy 64:2–6

    PubMed  CAS  Google Scholar 

  85. Lehmann JF, Price R, deLateur BJ, Hinderer S, Traynor C (1989) Spasticity quantitative measurements as a basis for assessing effectiveness of therapeutic intervention. Arch Phys Med Rehabil 70:6–15

    PubMed  CAS  Google Scholar 

  86. The Little Club (1959) Memorandum on terminology and classification of “cerebral palsy”. Cereb Palsy Bull 1:27–35

    Google Scholar 

  87. Maltais DB, Pierrynowski MR, Galea VA, Bar-Or O (2005) Physical activity level is associated with the O2 cost of walking in cerebral palsy. Med Sci Sports Exerc 37(3):347–353

    PubMed  Google Scholar 

  88. Maltais D, Bar-Or O, Galea V, Pierrynowski M (2001) Use of orthoses lowers the O2 cost of walking in children with spastic cerebral palsy. Med Sci Sports Exerc 33:320–325

    PubMed  CAS  Google Scholar 

  89. Mandac BR, Hrvitz EA, Nelson VS (1993) Hyperthermia associated with baclofen withdrawal and increased associated spasticity. Arch Phys Med Rehabil 74(1):96–97

    PubMed  CAS  Google Scholar 

  90. Mandigo CE, Anderson RCE (2006) Management of childhood spasticity: a neurosurgical percpective. Pediatr Ann 35(5):354–362

    PubMed  Google Scholar 

  91. Martin JE, Epstein LH (1976) Evaluating treatment effectiveness in cerebral palsy: single subject designs. Phys Ther 56(3):285–294

    PubMed  CAS  Google Scholar 

  92. Mayo NE (1991) The effect of physical therapy for children with motor delay and cerebral palsy. Am J Phys Med Rehabil 70:258–267

    PubMed  CAS  Google Scholar 

  93. Mathew A, Mathew C, Thomas M, Antonisamy B (2005) The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy. J Trop Med 51(2):109–113

    Google Scholar 

  94. Miller VS (1993) Pharmacologic management of neonatal cerebral ischemia and hemorrhage: old and new directions. J Child Neurol 8:7–18

    PubMed  CAS  Google Scholar 

  95. Mills VM (1994) Electromyographic results of inhibitory splinting. Phys Ther 64:190

    Google Scholar 

  96. Mooney JF, Koman LA, Smith BP (2003) Pharmacologic management of spasticity in cerebral palsy. J Pediatr Orthop 23(5):679–686

    PubMed  Google Scholar 

  97. Msall ME, DiGaudio K, Rogers BT, LaForest S, Catanzaro NL, Campbell J, Wilczenski F, Duffy LC (1994) The Functional Independence Measure for Children (WeeFIM). Conceptual basis and pilot use in children with developmental disabilities. Clin Pediatr (Philadelphia) 33(7):421–430 (Review)

    CAS  Google Scholar 

  98. Neilson PD, McCaughey J (1982) Self-regulation of spasm and spasticity in cerebral palsy. J Neurol Neurosurg Psychiatr 45:320–330

    PubMed  CAS  Google Scholar 

  99. Nelson KB (1989) Relationship of intrapartum and delivery events to long-term neurologic outcome. Clin Perinatol 16:995–1007

    PubMed  CAS  Google Scholar 

  100. Nogen AG (1979) Effectof dantrolene sodium on the incidence of seizures in children with spasticity. Child’s Brain 5(4):420–425

    PubMed  CAS  Google Scholar 

  101. Nordmark E, Anderson G (2002) Wartenberg pendulum test: objective quantification of muscle tone in children with spastic diplegia undergoing selective dorsal rhizotomy. Dev Med Child Neurol 44(1):26–33

    PubMed  Google Scholar 

  102. Nordmark E, Anderson G (2002) Wartenberg pendulum test: objective quantification of change in tone in children with spastic diplegia undergoing selective dorsal rhizotomy. Dev Med Child Neurol 44(1):26–33

    PubMed  Google Scholar 

  103. Nordmark E, Hagglund G, Jarnlo GB (1997) Reliability of the Gross Motor Function Measure in cerebral palsy. Scand J Rehabil Med 29:25–28

    PubMed  CAS  Google Scholar 

  104. Norkin C, White DJ (1985) Measure of joint motion: a guide to goniometry. FA Davis, Philadelphia

    Google Scholar 

  105. Odeen I (1981) Reduction in muscular hypertonus by long-term muscle stretch. Scand J Rehabil Med 13:93–99

    PubMed  CAS  Google Scholar 

  106. Ottenbacher KJ, Biocca Z, DeCremer G, Gevelinger M, Jedlovec KB, Johnson MB (1986) Quantitative analysis of the effectiveness of pediatric therapy: emphasis on the neurodevelopmental treatment approach. Phys Ther 66:1095–1101

    PubMed  CAS  Google Scholar 

  107. Palmer FB, Shapiro BK, Wachtel RC, Allen MC, Hiller JE, Harryman SE, Mosher BS, Meinert CL, Capute AJ (1988) Effects of physical therapy on cerebral palsy. N Engl J Med 318:803–808

    Article  PubMed  CAS  Google Scholar 

  108. Pape KE, Kirsch SE, Galil A, Boulton JE, White A, Chipman M (1993) Neuromuscular approach to the motor deficits of cerebral palsy: a pilot study. J Pediatr Orthop 13:628–633

    PubMed  CAS  Google Scholar 

  109. Parziale JR, Akelman E, Herz DA (1993) Spasticity: pathophysiology and management. Orthop 16(7):803–811

    Google Scholar 

  110. Peterson T, Klemar B (1988) Electrical stimulation as a treatment in lower extremity spasticity. J Neurol Rehabil 2:103–108

    Google Scholar 

  111. Pierce SR, Daly K, Gallagher KG, Gershkoff AM, Schaumburg SW (2002) Constraint-induced therapy for a child with hemiplegic cerebral palsy: a case report. Arch Phys Med Rehabil 83:1462–1463

    PubMed  Google Scholar 

  112. Pirpiris M, Graham HK (2004) Uptime in children with cerebral palsy. J Pediatr Orthop 24(5):521–528

    PubMed  Google Scholar 

  113. Pletzek UM, Heinen F, Schwerin A, Berweck S (2005) Botulinum treatment in children with spastic movement disorders: a pilot study. Pediatr Neurol 31:109–113

    Google Scholar 

  114. Preissner KS (2001) The effects of serial casting on spasticity: a literature review. Occup Ther Health Care 14(2):99–106

    Google Scholar 

  115. Reeuwojk A, van Shie PEM, Becher JG, Kwakkel G (2006) Effects of boutlinum toxin type A on upper limb function in children with cerebral palsy: a systematic review. Clin Rehabil 20(5):375–387

    Google Scholar 

  116. Robinson RO (1973) The frequency of other handicaps in children with cerebral palsy. Dev Med Child Neurol 15:305–316

    Article  PubMed  CAS  Google Scholar 

  117. Rosenbaum PL, Walter SD, Hanna SE, Palisano RJ, Russell DJ, Raina P, Wood E, Barlett DJ, Galuppi BE (2002) Prognosis for gross motor function in cerebral palsy: Creation of Motor Development Curves. JAMA 288(11):1357–1363

    PubMed  Google Scholar 

  118. Russell D, Rosenbaum P, Cadman D, Gowland C, Hardy S, Jarvis S (1989) The gross motor function measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol 31:341–352

    Article  PubMed  CAS  Google Scholar 

  119. Sala D, Grant AD (1995) Prognosis for ambulation in cerebral palsy. Dev Med Child Neurol 37:1020–1026

    Article  PubMed  CAS  Google Scholar 

  120. Salkorpi T, Sajaniemi N, Hällback H, Kari A, Rita H, Von Wendt L (1997) Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years. Acta Paediatr 86:294–298

    Google Scholar 

  121. Sanders JO, McConnell SL, King R, Landford A, Montpetit K, Gates P, Rich M, Shepard K, Cupp T, Haynes R, Bush P, Tahir F, Santiago J, Lighter DE, Smrcina C, Niederpruem ML, McDonald C, Curry DB (2006) A prospective evaluation of the WeeFIM in pareints with cerebral palsy undergoing orthopedic surgery. J Pediatr Orthop 26(4):542–546

    PubMed  Google Scholar 

  122. Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW, Task Force on Childhood Motor Disorders (2003) Classification and definitions of disorders causing hypertonia in children. Pediatrics 111:e89–e97

    PubMed  Google Scholar 

  123. Sankey RJ, Anderson DM, Young JA (1989) Characteristics of ankle-foot orthoses for management of the spastic lower limb. Dev Med Child Neurol 31:466–470

    Article  PubMed  CAS  Google Scholar 

  124. Scholtes VA, Dallmeijer AJ, Knol DL, Speth LA, Maathuis CG, Jongerius PH, Beecher JG (2006) The combined effect of lower-limb multilevel Botlulinum Toxin type A and comprehensive rehabilitation of mobility in children with cerebral pals: a randomized clinical trial. Arch Phys Med Rehabil 87:1551–1558

    PubMed  Google Scholar 

  125. Semenova KA, Bobnova VA, Vinogradova LJ, Tikunova NP (1986) Cryotherapy in the complex restorative treatment of children with infantile cerebral palsy. Zh Nevropatol Psikhiatr Im SS Korsakova 86(10):1459–1463

    CAS  Google Scholar 

  126. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH, National Institute of Child Health and Human Development Neonatal Research Network (2005) Whole-body hypothermia for neonates with hypoxic–ischemic encephalopathy. N Engl J Med 353:1574–1584

    PubMed  CAS  Google Scholar 

  127. Singer BJ, Singer KP, Allison GT (2003) Evaluation of extensibility, passive torque and stretch reflex responses in triceps surae muscles following serial casting to correct spastic equinovarus deformity. Brain Inj 17(4):309–324

    PubMed  CAS  Google Scholar 

  128. Siracusa C, Taynor M, Geletka B, Overby A (2005) Effectiveness of biomechanical intervention in children with spastic diplegia. Pediatr Phys Ther 17(1):83–84

    Google Scholar 

  129. Smelt HR (1989) Effect of an inhibitive weight-bearing mitt on tone reduction and functional performance in a child with cerebral palsy. Phys Occup Ther Pediatr 9(2):53–80

    PubMed  CAS  Google Scholar 

  130. Steinbok P (2006) Selection of treatment modalities in children with spastic cerebral palsy. Neurosurg Focus 21(2):e4

    Article  PubMed  Google Scholar 

  131. Sussman M (1979) Preliminary report: the role of short-leg tone reducing casts as an adjunct to physical therapy of patients with cerebral palsy. Johns Hopkins Med J 145:112–114

    PubMed  CAS  Google Scholar 

  132. Sutherland DH, Schottsteadt ER, Larsen LJ, Ashley RK, Callendar PM, James PM (1969) Clinical and electromyographic study of spastic children with internal rotation gait. J Bone Jt Surg 51-A(6):70–1082

    Google Scholar 

  133. Tanaka H, Fukada I, Miyamoto A, Oka R, Cho K, Fujieda K (2004) Effects of tizanidine for refractory sleep disturbance in disabled children with spastic quadriparesis. No to Hattatsu 36(6):455–460

    PubMed  Google Scholar 

  134. Tardieu C, Huet de la Tour E, Bret MD, Tardieu G (1982) Muscle hypoextensibility in children with cerebral palsy. Arch Phys Med Rehabil 63:97–110

    PubMed  CAS  Google Scholar 

  135. Tardieu C, Lespargot A (1988) For how long must the soleus muscle be stretched each day to prevent contracture? Dev Med Child Neurol 30(1):3–10

    Article  PubMed  CAS  Google Scholar 

  136. Tardoff K (1986) Spontaneous remission in cerebral palsy. Neuropediatrics 17:19–22

    Google Scholar 

  137. Taub E, Lum P, Hardin P, Mark V, Uswatte G (2005) AutoCITE automated delivery of CI therapy with reduced effort by therapists. Stroke 36:1301–1304

    PubMed  Google Scholar 

  138. Tirosh E, Rabino S (1989) Physiotherapy for children with cerebral palsy. Am J Dis Child 143:551–553

    Google Scholar 

  139. Toner LV, Cook, Elder GCB (1998) Improved ankle function in children with cerebral palsy after computer-assisted motor learning. Dev Med Child Neurol 40:829–835

    Article  PubMed  CAS  Google Scholar 

  140. Tscharnuter I (2002) Clinical application of dynamic theory concepts according to Tscharnuter Akademie for Movement Organization (TAMO) therapy. Pediatr Phys Ther 14:29–37

    PubMed  Google Scholar 

  141. Tsorlakis N, Evaggelinou C, Grouios G, Tsorbatzoudis C (2004) Effect of intensive neurodevelopmental treatment in gross motor function of children with cerebral palsy. Dev Med Child Neurol 46(11):740–745

    PubMed  Google Scholar 

  142. Valvano J (2004) Activity-focused motor interventions for children with neurological conditions. Phys Occup Ther Pediatr 24(1):79–107

    Article  PubMed  Google Scholar 

  143. Verplankle D, Snape S, Salisbury CF, Jones PW, Ward AB (2005) A randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury. Clin Rehabil 19(2):117–125

    Google Scholar 

  144. Verotti A, Greco R, Spalice A, Chiarelli F, Iannetti P (2006) Phamacotherpay of spasticity in children with cerebral palsy. Pediatr Neurol 34:1–6

    Google Scholar 

  145. Wang R, Chan R, Tsai M (2000) Effects of thoraco-lumbar electrical sensory stimulation of knee extensor spasticity of persons who survived cerebrovascular accidents. J Rehabil Res Dev 37(1):73–79

    PubMed  CAS  Google Scholar 

  146. Wantabe T (2004) The role of therapy in spasticity management. Am J Phys Med Rehabil 84:S45–S49

    Google Scholar 

  147. Watkins CA (1999) Mechanical and neurophysiological changes in spastic muscles: serial casting in spastic equinovarus following traumatic brain injury. Physiotheraphy 85(11):603–609

    Google Scholar 

  148. Wei S, Su-Juan W, Yuan-Gui L, Hong Y, Xiu-Juan X, Xiao-Mei S (2006) Reliability and validity of the GMFM-66 in 0-to 3-year-old children with cerebral palsy. Am J Phys Med Rehabil 85(2):141–147

    PubMed  Google Scholar 

  149. Williams PE, Goldspink G (1978) Changes in sarcomere length and physiological properties in immobilized muscle. J Anat 127(3):459–468

    PubMed  CAS  Google Scholar 

  150. Wong E, Man D (2005) Gross Motor Function Measure for children with cerebral palsy. Int J Rehabil Res 28(4):355–359

    PubMed  Google Scholar 

  151. Wu YW, Colford JM Jr (2000) Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 284:1417–1427

    PubMed  CAS  Google Scholar 

  152. Young RR, Delwaide PJ (1981) Drug therapy: spasticity. N Engl J Med 304:28–43

    Article  PubMed  CAS  Google Scholar 

  153. Zarfonte R, Lomard L, Elovic E (2004) Antispasmoticity medications: uses and limitations of enteral therapy. Am J Phys Med Rehabil 83(10):s50–s66

    Google Scholar 

  154. Ziv I, Blackburn N, Rang M, Koreska J (1984) Muscle growth in normal and spastic mice. Dev Med Child Neurol 26:94–99

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joan T. Gold.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ronan, S., Gold, J.T. Nonoperative management of spasticity in children. Childs Nerv Syst 23, 943–956 (2007). https://doi.org/10.1007/s00381-007-0396-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-007-0396-4

Keywords

Navigation